Endovascular treatment for thoracoabdominal and paravisceral aortic aneurysms
Official title: Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Run by University of California, San Francisco · NCT00483249 · Data updated 2026-11-12
This study is testing a less invasive way to treat certain types of aortic aneurysms using a stent-graft to see if it can reduce pain and recovery time compared to traditional surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 2 sites (San Francisco, California and 1 other locations) |
| Status | Recruiting |
| Started | May 2005 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT00483249 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with significant aortic aneurysms who meet specific size and anatomical criteria and have a life expectancy of more than two years.
✕Probably not a fit
Patients with free ruptures of the aneurysm, pregnancy, or serious systemic infections are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the safety and effectiveness of an endovascular approach to treat thoracoabdominal and paravisceral abdominal aortic aneurysms. The procedure involves placing a stent-graft over the aneurysm through small incisions in the groins and arm, as opposed to traditional surgery which requires a large incision. The goal is to reduce pain, minimize complications, and shorten hospital stays compared to standard surgical methods. Participants will be monitored for outcomes related to the success of the stent-graft placement and overall recovery.
Why it matters
Potential benefit: If successful, this approach could offer a less invasive treatment option with fewer complications for patients with aortic aneurysms.
How similar studies have gone: Other studies have shown promising results with endovascular techniques for aortic aneurysms, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Aortic aneurysms: * greater than or equal to 6 cm in diameter in men, * greater than or equal to 5.5 cm in diameter in women, * and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year, * and/or iliac aneurysms larger than 4 cm in diameter. 2. Anticipated mortality comparable to published rates with conventional surgical treatment. 3. Life expectancy more than 2 years. 4. Ability to give informed consent. 5. Willingness to comply with follow-up schedule. 6. Suitable arterial anatomy for endovascular repair. Exclusion Criteria 1. Free rupture of the aneurysm. 2. Pregnancy. 3. Known allergy to Nitinol, stainless steel, or polyester. 4. Unwillingness or inability to comply with the follow up schedule. 5. Serious systemic or groin infection. 6. Uncorrectable coagulopathy.
Where it's running
-
Division of Vascular Surgery, SFVAMC
San Francisco, California, United States Recruiting -
Division of Vascular Surgery, UCSF
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Warren J Gasper, MD — University of California, San Francisco
- Study coordinator: Warren J Gasper, MD
- Email: warren.gasper@ucsf.edu
- Phone: 415 750 2115
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Femorofemoral versus left‑heart bypass for open thoracoabdominal aortic aneurysm repair
This will test whether femorofemoral bypass or left‑heart bypass works better for adults having open repair of a thoracoabdominal aortic aneurysm.
-
TAMBE device post-marketing safety and effectiveness for thoracoabdominal and pararenal aortic aneurysms
This tests whether the TAMBE multi-component device (GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis) is safe and works well for people treated for thoracoabdominal or pararenal aortic aneurysms in Japan.
-
BAO-G technique for repairing complex thoracoabdominal and abdominal aortic aneurysms
This study will try the BAO-G endovascular technique, which uses off-the-shelf iliac branched devices to rebuild visceral branches in patients with complex thoracoabdominal or abdominal aortic aneurysms who are candidates for endovascular repair.
-
Evaluation of a 3D-Printed Stent-Graft for Aortic Aneurysms
This study is testing a new 3D-printed stent-graft to see if it works better and is safer than standard devices for treating complex abdominal aortic aneurysms in about 100 patients.
-
Outcomes after physician-modified fenestrated and branched stent grafts for complex aortic aneurysms
This study will test whether physician-modified fenestrated and branched stent grafts are safe and effective for people with juxtarenal, pararenal, or thoracoabdominal aortic aneurysms who are high risk for open surgery.
-
Using a multibranched stent graft to treat thoracoabdominal aortic aneurysms
This study is testing a new type of stent graft to see if it can safely and effectively treat thoracoabdominal aortic aneurysms in patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.